Get Started

EOCN

NASD Eocene Ltd.
Nov 4, 2026 · 9:57 PM ET EOD Market Closed

$2.77 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.77, $0.04 below the day’s high of $2.81

YTD change
-31.26%
vs 20-day SMA
-11.33%
vs 200-day SMA
N/A

Price ranges

Previous day
$2.69 $3.00
open $2.87 close $2.81
-$0.06 (-2.09%)
Today
$2.77 $2.81
open $2.80 now $2.77
-$0.03 (-1.06%)
Past week
$2.69 $3.48
from $3.08 now $2.77
-$0.31 (-10.06%)
Past month
$2.33 $3.63
from $3.36 now $2.77
-$0.59 (-17.55%)
This year
$2.33 $4.88
from $4.03 now $2.77
-$1.26 (-31.26%)

Price & Performance

-1.26 (-31.26%) / 6M

$2.67$3.16$3.64$4.13Sep 10Oct 7Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 77.5% away from all-time highs of $12.32
  • EOCN is down 31% since the beginning of the year
  • EOCN is down 31% over the past 12 months
  • EOCN is down 18% over the past 1 month
  • 1% of all EOCN investors are betting against EOCN

EOCN reads poor: the 12-month move is -31.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-2.8598
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $-8585410.0
Beta 2.78

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$11.4M
Debt$129.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $2.9M

Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $478.48 +3.73%
MRNA Moderna, Inc. $258.38 +13.11%
RVMD Revolution Medicines, Inc. $199.70 +2.82%
ROIV Roivant Sciences Ltd. $38.23 +6.08%
BNTX BioNTech SE Sponsored ADR $90.70 +4.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.